Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

A REVIEW ON GUTFLORA, BRAINGUT AXIS AND ALZHEIMER DISEASE

Simachal Panda

Alzheimer’s disease (AD) is a neurodegenerative disease in which pathophysiological changes occurs in amyloid plaque and neurofibrillary tangles. The studies have been revealed that micro biota-gut brain axis. Gut brain has various pathways of connection. Gut and spinal cord are connected together by vagus nerve. Brain stem nuclei may require direct connectivity with brain. Enteric nervous system may stimulated by gut bacteria. Blood circulation may connect brain and gut. Probiotics are the microorganisms those give beneficial action to host body. Probiotics have the efficiency to provide substances which are beneficial for inflammation and related disease. Stress, antibiotic consumption, poor eating habits may lead to health risks due to micro flora imbalance in gut. The gut micro beta producing chemicals such as monoamine and amino acid through lymphatic and vascular system may reach to brain. Its direct link with micro biota brain gut connectivity. Gut micro beta are responsive to neurotransmitters signaled by brain. Flora have the ability to synthesize and release neuron transmitters as serotonin, dopamine and histamine. “neuroinflammation” occurs due to neuron release substance. It is common in AD. In this context the idea developed is probiotics can reduce anti-inflammatory activity in AD by alteration in gut micro biota, which is known as dysbiosis.It can be due to gut infection, age. Healthy diatery pattern along with balanced prebiotics and probiotics decline in neurocognitive effects in AD.